Shanghai Nianxing Industrial Co., Ltd
China
Product Name: 1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL)
Price:
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL)
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

823809-16-1

823809-16-1 structure

823809-16-1 structure

Name: 1H-IMIDAZO[4,5-C]QUINOLINE-1-PROPANAMINE,4-AMINO-2-(ETHOXYMETHYL)
Chemical Name: 1-(3-aminopropyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine
CAS Number: 823809-16-1
Molecular Formula: C₁₆H₂₁N₅O
Molecular Weight: 299.37100
Create Date: 2018-10-14 06:52:42
Modify Date: 2024-01-10 22:26:39

Name	1-(3-aminopropyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine
Synonyms	1H-Imidazo[4,5-c]quinoline-1-propanamine,4-amino-2-(ethoxymethyl) 1-(3-aminopropyl)-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine 1-(3-aminopropyl)-2-(etoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine

Molecular Formula	C₁₆H₂₁N₅O
Molecular Weight	299.37100
Exact Mass	299.17500
PSA	92.71000
LogP	2.68240
Storage condition	2-8°C

1026925-29-0 structure

1026925-29-0

~81%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ; Location in patent: Page/Page column 82-83 ;

50332-66-6 structure

50332-66-6

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

611-36-9 structure

611-36-9

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

39061-97-7 structure

39061-97-7

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

860173-10-0 structure

860173-10-0

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

1080007-46-0 structure

1080007-46-0

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

852719-50-7 structure

852719-50-7

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

1080007-44-8 structure

1080007-44-8

~%

823809-16-1 structure

823809-16-1

Literature: Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB Patent: US2011/136801 A1, 2011 ;

1510714-37-0 structure

1510714-37-0

~%

823809-16-1 structure

823809-16-1

Literature: Cayla; Vernejoul, Fabienne; Debin, Arnaud; Drocourt, Daniel; Perouzel, Eric; Tiraby, Gérard; Lioux, Thierry Patent: EP2674170 A1, 2013 ;

Precursor 9
1026925-29-0 50332-66-6 611-36-9 39061-97-7
860173-10-0 1080007-46-0 852719-50-7 1080007-44-8
1510714-37-0
DownStream 0